Beijing Tide Pharmaceutical
Beijing Tide Pharmaceutical is a Chinese developer in Beijing that sponsors 2 registered cancer trials of TCC1727.
Overview
Beijing Tide Pharmaceutical appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 1/2), testing TCC1727 in patients with advanced solid tumors, solid cancers, nsclc (advanced non-small cell lung cancer), gastric (stomach) cancer. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.
Similar pages
not linked directly; found by shared links- CompanyBeijing Gene Key Life Technology
Shares the tags china, registry-only.
- CompanyBeijing Konruns Pharmaceutical
Shares the tags china, registry-only.
- CompanyBeijing Mabworks Biotech
Shares the tags china, registry-only.
- CompanyBeijing Pearl Biotechnology Limited Liability Company
Shares the tags china, registry-only.
- CompanyBeijing Scitech-Mq Pharmaceuticals
Shares the tags china, registry-only.
- CompanyBinhui Biopharmaceutical
Shares the tags china, registry-only.
- CompanyChengdu Zenitar Biomedical Technology
Shares the tags china, registry-only.
- CompanyHenan Genuine Biotech
Shares the tags china, registry-only.